Skip to main content

Table 3 Summary statistics on price dispersion relative to International Reference Price across sectors and medicine groups

From: Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology

 

Public sector – Lowest Price Generic

Source list

n=

Mean MPR

Median MPR

Min

Max

Full sample

Global

13

1.208

1.256

0.131

2.362

Supplementary

33

0.886

0.758

0.147

2.672

All

46

0.977

0.776

0.131

2.672

NCD drugs only

Global

7

0.955

0.756

0.131

1.940

Supplementary

19

0.805

0.627

0.147

2.672

All

26

0.846

0.629

0.131

2.672

Infectious disease drugs only

Global

4

1.697

1.675

1.076

2.362

Supplementary

12

0.905

0.875

0.271

1.648

All

16

1.103

1.118

0.271

2.362

Uncategorized drugs

All

4

1.327

1.482

0.784

1.558

Essential Medicines

In EML

39

1.038

0.890

0.131

2.672

 

Not in EML

7

0.637

0.631

0.147

1.440

 

Private sector retail - Lowest Price Generic

  

Full sample

Global

12

2.286

2.330

0.784

4.430

Supplementary

43

1.537

1.411

0.325

3.890

All

55

1.700

1.521

0.325

4.430

NCD drugs only

Global

6

2.290

2.465

1.019

3.527

Supplementary

26

1.301

1.171

0.325

3.338

All

32

1.486

1.202

0.325

3.527

Infectious disease drugs only

Global

4

2.810

2.983

0.846

4.430

Supplementary

15

1.950

1.698

0.330

3.890

All

19

2.131

1.981

0.330

4.430

Uncategorized drugs

All

4

1.370

1.514

0.784

1.668

Essential Medicines

In EML

46

1.777

1.562

0.325

4.430

 

Not in EML

9

1.308

1.371

0.379

2.309

 

Private sector retail - Originator Brand

  

Full sample

Global

2

8.750

8.750

1.391

16.110

Supplementary

6

2.014

1.400

0.597

5.902

All

8

3.698

1.489

0.597

16.110

Essential Medicines

In EML

7

1.925

1.391

0.597

5.902

Not in EML

1

16.110

16.110

16.110

16.110

 

Private sector clinics - Lowest Price Generics

  

Full sample

Source list

n=

Mean MPR

Median MPR

Min

Max

Global

13

2.381

2.604

0.784

4.430

Supplementary

41

1.537

1.470

0.325

3.890

All

54

1.740

1.573

0.325

4.430

NCD drugs only

Global

7

2.335

2.604

1.019

3.527

Supplementary

26

1.339

1.067

0.325

3.443

All

33

1.551

1.213

0.325

3.527

Infectious disease drugs only

Global

4

2.814

2.968

0.889

4.430

Supplementary

13

1.933

1.698

0.335

3.890

All

17

2.141

1.981

0.335

4.430

Uncategorized drugs

All

4

1.603

1.531

0.784

2.568

Essential Medicines

In EML

45

1.807

1.624

0.325

4.430

 

Not in EML

9

1.405

1.371

0.379

2.568

 

Private sector clinics - Originator Brands

  

Full sample

Global

2

8.750

8.750

1.391

16.110

Supplementary

6

2.094

1.545

0.597

5.902

All

8

3.758

1.634

0.597

16.110

Essential Medicines

In EML

7

1.993

1.391

0.597

5.902

Not in EML

1

16.110

16.110

16.110

16.110

  1. Source: Authors’ Data
  2. Note: n = Number of survey medicines with MPR values. Mean and median MPR summarize all calculated median price ratios in the indicated groups, with the MPR for each medicine using the median unit price in local currency compared with the International Reference Price in local currency. Minimum and maximum MPR refer to the lowest and highest MPR observed across medicines in each group
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us